Pfizer Inc. (PFE)
27.98
-0.09
(-0.32%)
USD |
NYSE |
Aug 24, 16:00
27.96
-0.02
(-0.07%)
After-Hours: 20:00
Pfizer Price to Book Value : 1.872 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.878 |
| August 20, 2026 | 1.859 |
| August 19, 2026 | 1.889 |
| August 18, 2026 | 1.823 |
| August 17, 2026 | 1.798 |
| August 14, 2026 | 1.792 |
| August 13, 2026 | 1.793 |
| August 12, 2026 | 1.760 |
| August 11, 2026 | 1.781 |
| August 10, 2026 | 1.810 |
| August 07, 2026 | 1.790 |
| August 06, 2026 | 1.753 |
| August 05, 2026 | 1.727 |
| August 04, 2026 | 1.700 |
| August 03, 2026 | 1.674 |
| July 31, 2026 | 1.673 |
| July 30, 2026 | 1.666 |
| July 29, 2026 | 1.682 |
| July 28, 2026 | 1.689 |
| July 27, 2026 | 1.650 |
| July 24, 2026 | 1.642 |
| July 23, 2026 | 1.673 |
| July 22, 2026 | 1.660 |
| July 21, 2026 | 1.668 |
| July 20, 2026 | 1.656 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.676 |
| July 16, 2026 | 1.682 |
| July 15, 2026 | 1.660 |
| July 14, 2026 | 1.622 |
| July 13, 2026 | 1.638 |
| July 10, 2026 | 1.617 |
| July 09, 2026 | 1.622 |
| July 08, 2026 | 1.609 |
| July 07, 2026 | 1.610 |
| July 06, 2026 | 1.587 |
| July 02, 2026 | 1.627 |
| July 01, 2026 | 1.598 |
| June 30, 2026 | 1.611 |
| June 29, 2026 | 1.541 |
| June 26, 2026 | 1.536 |
| June 25, 2026 | 1.497 |
| June 24, 2026 | 1.521 |
| June 23, 2026 | 1.564 |
| June 22, 2026 | 1.586 |
| June 18, 2026 | 1.595 |
| June 17, 2026 | 1.640 |
| June 16, 2026 | 1.647 |
| June 15, 2026 | 1.644 |
| June 12, 2026 | 1.658 |
| June 11, 2026 | 1.655 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.739 |
| Eli Lilly & Co. | 34.67 |
| Merck & Co., Inc. | 8.873 |
| Bristol Myers Squibb Co. | 6.161 |
| Viatris, Inc. | 1.340 |
Price to Book Value Related Metrics
| PE Ratio | 37.05 |
| PS Ratio | 2.507 |
| Price to Free Cash Flow | 14.54 |
| Price | 27.98 |
| Earnings Yield | 2.70% |
| Market Cap | 159.46B |
| Operating PE Ratio | 9.434 |
| Normalized PE Ratio | 11.55 |